Shanghai Pharma, Primavera Complete $239M Buyout Of Australia’s Vitaco

For Digital Subscribers Only

Chinese drugmaker Shanghai Pharmaceuticals Holding Co., Ltd. and private equity firm Primavera Capital have completed a US$239 million buyout to acquire Australian vitamins maker Vitaco Holdings, the companies announced today.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

China Expert network

RELATED NEWS



LEAVE A REPLY